The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 30, 2018

Filed:

Aug. 13, 2013
Applicant:

Medtronic Minimed, Inc., Northridge, CA (US);

Inventors:

Anirban Roy, Calabasas, CA (US);

Desmond Barry Keenan, Hollywood, CA (US);

John J. Mastrototaro, Los Angeles, CA (US);

Benyamin Grosman, North Hollywood, CA (US);

Neha J. Parikh, West Hills, CA (US);

Assignee:

MEDTRONIC MINIMED, INC., Northridge, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G06Q 50/00 (2012.01); A61M 5/172 (2006.01); G06F 19/00 (2011.01); A61B 5/145 (2006.01); A61B 5/00 (2006.01);
U.S. Cl.
CPC ...
A61M 5/1723 (2013.01); A61B 5/14532 (2013.01); A61B 5/4839 (2013.01); G06F 19/345 (2013.01); G06F 19/3412 (2013.01); G06F 19/3468 (2013.01);
Abstract

A controller for an insulin infusion device includes at least one processor device and at least one memory element that cooperate to provide a processor-implemented closed-loop start-up module. The start-up module is operated to initiate a closed-loop mode of the infusion device and to obtain a most recent sensor glucose value for the user. The start-up module also calculates a difference between the most recent sensor glucose value and a target glucose setpoint value. When the difference is less than or equal to a threshold value, the closed-loop insulin infusion rate is adjusted over time, based on a fixed final target glucose value that is derived from the target glucose setpoint value. When the difference is greater than the threshold, the infusion rate is adjusted over time, based on a dynamic final target glucose value that decreases over time toward the target glucose setpoint value.


Find Patent Forward Citations

Loading…